Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-20 @ 3:45 AM
Study NCT ID:
NCT01165112
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2010-06-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
Sponsor:
University of Washington
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PSOC 2502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |